in the news
Law360 Notes O’Melveny’s Role in Thermo Fisher’s US$1.5 Billion Debt OfferingAugust 11, 2017
The August 11, 2017, edition of Law360 reported that O’Melveny represented the underwriters of Thermo Fisher Scientific Inc.’s US$1.5 billion debt offering, which will help fund its acquisition of Dutch pharmaceutical company Patheon NV. The underwriters included Goldman Sachs, Bank of America Merrill Lynch, Citigroup, and JP Morgan.
The publication also noted that O’Melveny represented Goldman Sachs, BofA Merrill Lynch, and Citigroup as the underwriters of Thermo Fisher’s recent stock offering.